We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
+15.57%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$200M
AUM Growth
+$16.2M
Cap. Flow
-$1.8M
Cap. Flow %
-0.9%
Top 10 Hldgs %
99.17%
Holding
12
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CDLX icon
Cardlytics
CDLX
+$1.8M

Sector Composition

Rank Sector Weight
1 Healthcare 61.13%
2 Communication Services 32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDLX icon
1
Cardlytics
CDLX
$22.1M
$63.9M 32%
255,263
-8,363
-3% -$1.8M
FATE icon
2
Fate Therapeutics
FATE
$293M
$40.3M 20.17%
2,473,186
– –
STIM icon
3
Neuronetics
STIM
$137M
$26.4M 13.24%
824,765
– –
RNAC icon
4
Cartesian Therapeutics
RNAC
$227M
$25M 12.51%
53,560
– –
KALA icon
5
KALA BIO
KALA
$13.6M
$18.3M 9.18%
744
– –
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
$13.7M 6.87%
368
– –
TRVN
7
DELISTED
Trevena, Inc.
TRVN
$4.35M 2.18%
3,286
– –
XFOR icon
8
X4 Pharmaceuticals
XFOR
$377M
$3.03M 1.52%
10,383
– –
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.53M 0.77%
246,076
– –
ATYR
10
aTyr Pharma
ATYR
$47.1M
$1.49M 0.74%
130,571
– –
PULM icon
11
Pulmatrix
PULM
$6.21M
$1.33M 0.67%
17,972
– –
DARE icon
12
Dare Bioscience
DARE
$18.6M
$318K 0.16%
27,187
– –

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q3 2018 Portfolio in Review

As of Q3 2018, Polaris Venture Management Co V held 12 positions worth $200M, up 8.9% from $183M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 0%. Polaris Venture Management Co V opened no new positions and made no exits, leaving the 12-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 61% a quarter earlier, followed by Communication Services.

  • Polaris Venture Management Co V's biggest Q3 2018 reduction was Cardlytics, cutting an estimated $1.8M.
  • Polaris Venture Management Co V's ten largest holdings make up 99% of its $200M portfolio in Q3 2018.
  • Polaris Venture Management Co V opened 0 new positions and closed 0 in Q3 2018.
  • Polaris Venture Management Co V's portfolio value rose 8.9% quarter-over-quarter to $200M.

Based on Polaris Venture Management Co V's 13F filing for Q3 2018, filed 13 Nov 2018.